MicroRNA-195 protects against dementia induced by chronic brain hypoperfusionvia its anti-amyloidoge

来源 :第十六届全国神经精神药理学学术会议 | 被引量 : 0次 | 上传用户:octaaug
下载到本地 , 更方便阅读
声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架
论文部分内容阅读
  OBJECTIVE To evaluate the effect of microRNA on memory impairment of chronic brain hypoperfusion (CBH)rats generated by bilateral common carotid artery occlusion (2VO).METHODS Morris water mazewas performed to evaluate cognitive ability.Expression of miR-195, BACE1 and APP in hippocampus and cortex were evaluatedafterrats performed by 2VO, injected by lentiviral vector-mediated overexpression of miR-195(lenti-pre-miR195) and/or antisense molecule (lenti-pre-AMO-miR-195).RESULTS We show here CBH significantly decreased the learning and memory ability and upregulated expression of APP and BACE1 proteins in the hippocampus and cortex of rats, as evaluated by western blot and immunofluorescence.In reciprocal, qRT-PCR analysis showed that microRNA-195(miR-195) was downregulated in both the hippooampus and cortex of rats following CBH,and in the plasma of dementia patients.APP and BACE1 proteins were downregulated by miR-195 overexpression,upregulated by miR-195 inhibition, and unchanged by binding-site mutation or miR-masks, indicating that APP and BACE1 are two potential targets for miR-195.Knockdown of endogenous miR-195 by elicited dementia in rats,whereas overexpression of miR-195 using lenti-pre-miR-195 reduced dementia vulnerability triggered by 2VO.Additionally, chromatin immunoprecipitation analysis showed that NF-κB was bound to the promoter region of miR-195 and inhibited its expression.CONCLUSION MiR-195 may play a key role in determining dementia-susceptibility in 2VO rats by regulating APP and BACE1 expression at the post-transcriptional level, and exogenous complement of miR-195 may be a potentiallyvaluable anti-dementia approach.
其他文献
Depression is the most common non-motor syndrome of Parkinsons disease (PD).Recent clinical trials have evaluated effectiveness of traditional Chinese medicine (TCM) in the treatment of depression in
OBJECTIVE To determine the abnormal generation of Aβ and NFT in brain induced by complex Aβ25-35 using the complex Aβ25-35 successful model rats.And elucidate the improvement and effective mechanism o
OBJECTIVE To confirm the brains neurogliocyte proliferation and activation induced by complex Aβ25-35 using the successful model rats.And, through examination of neurogliocyte number and related to ac
OBJECTIVE To study the apoptotic factors abnormalities of mitochondrial apoptotic pathway in cerebral corex of rats injected β-amyloid beta protein 25-35 (Aβ25-35) in combination with aluminum trichlo
OBJECTIVE To investigate the effect of clk1 gene in MPTP mouse model to identify the function of clk1 gene in Parkinsons disease.METHODS Subchronic MPTP mouse model (MPTP, 30 mg·kg-1, 5 d) was employe
OBJECTIVE To investigate the neuroprotective role of naringenin and delineate its mechanism of action against 6-hydroxydopamine(6-OHDA)-induced neurotoxicity in models of Parkinsons disease (PD) both
OBJECTIVE AND METHODS To understand how the capabilities of neural coding of spatial cognition is formed during the development of neural circuitry,the role of the inhibitory neurotransmission within
OBJECTIVE To investigate the effect and underlying mechanism of Ligustilide on learning and memory in a double-transgenic AD mouse model (APP/PS1)that develops cognitive deficits as well as pathologic
OBJECTIVE To investigate the potential roles of chemokine-like factor 1 (CKLF1), a newly cloned chemotactic cytokine, in the cortical neuronal migration.METHODS The organotypic brain slice cultures at
OBJECTIVE Ischemic stroke is currently treated with thrombolytic therapy with a drawback to induce hemorrhagic transformation if applied beyond its relatively narrow treatment time window.The present